Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

303
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
303
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

125
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
125
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

149
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
149
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

2.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.4K
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

218
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
218
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

555
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
555

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Society of Thoracic Surgeons (STS)/World Society for Pediatric and Congenital Heart Surgery (WSPCHS)/European Congenital Heart Surgeons Association (ECHSA) Expert Opinion on the Role of Exercise Testing in Determining Optimal Timing of Pulmonary Valve Replacement in Tetralogy of Fallot.

The Annals of thoracic surgery·2026
Same author

"Hope is so fragile": parent perspectives on the care of children with single-ventricle heart disease.

Cardiology in the young·2026
Same author

Mitochondrial and Cardiolipin Adaptations to Ventricular Assist Device Support in Pediatric Versus Adult Failing Myocardium.

bioRxiv : the preprint server for biology·2026
Same author

Circulating miRNA-Protein Signatures Predict Outcomes in Pediatric Dilated Cardiomyopathy.

bioRxiv : the preprint server for biology·2026
Same author

Age-dependent Transcriptional Programs Distinguish Pediatric from Adult Dilated Cardiomyopathy.

medRxiv : the preprint server for health sciences·2026
Same author

The Fontan Outcomes Network: Findings After 2 Years and 1121 Participants.

Circulation·2026
Same journal

Diagnostic Tests for Stage B Heart Failure.

Current cardiology reports·2026
Same journal

Cardioimmunology of Myocarditis: Targeting the IL-1 Pathway.

Current cardiology reports·2026
Same journal

Antithrombotic Management in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation.

Current cardiology reports·2026
Same journal

Transcriptome Reprogramming in Heart Failure: The Hidden Splicing Code.

Current cardiology reports·2026
Same journal

Diagnosis and Management of Loeys-Dietz Syndrome: Evidence Gaps and Future Directions.

Current cardiology reports·2026
Same journal

Correction: Heart Disease in Older Women: Unique Challenges in Diagnosis and Management.

Current cardiology reports·2026
See all related articles

Related Experiment Video

Updated: Dec 9, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

25.0K

Important Considerations in Pediatric Heart Failure.

J Blake Wall1, Anastacia M Garcia2, Roni M Jacobsen2

  • 1New York Medical College, Valhalla, NY, USA.

Current Cardiology Reports
|September 10, 2020
PubMed
Summary
This summary is machine-generated.

Pediatric heart failure is a distinct condition with unique challenges. Advances in treatment require understanding its specific causes, management, and outcomes in children.

Keywords:
CardiomyopathyCongenital heart diseaseHeart failure

More Related Videos

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
09:31

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography

Published on: January 27, 2023

1.3K
Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
04:55

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model

Published on: May 26, 2023

1.1K

Related Experiment Videos

Last Updated: Dec 9, 2025

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

25.0K
Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography
09:31

Hemodynamic Precision in the Neonatal Intensive Care Unit using Targeted Neonatal Echocardiography

Published on: January 27, 2023

1.3K
Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
04:55

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model

Published on: May 26, 2023

1.1K

Area of Science:

  • Pediatric Cardiology
  • Cardiovascular Research
  • Clinical Pediatrics

Background:

  • Pediatric heart failure outcomes show limited improvement compared to adults.
  • Pediatric heart failure is increasingly recognized as a unique disease with age- and disease-specific myocardial adaptations.
  • Heterogeneous etiologies of pediatric heart failure complicate treatment responses and clinical trials.

Purpose of the Study:

  • To provide an overview of current knowledge on the causes, management, and outcomes of heart failure in children.
  • To highlight the unique aspects of pediatric heart failure compared to adult populations.
  • To identify essential considerations for advancing pediatric heart failure care.

Main Methods:

  • Review of contemporary scientific literature on pediatric heart failure.
  • Analysis of recent findings regarding disease mechanisms and therapeutic responses.
  • Synthesis of knowledge on causes, management strategies, and patient outcomes.

Main Results:

  • Pediatric heart failure exhibits distinct pathophysiological characteristics.
  • Therapeutic responses in children vary due to diverse etiologies.
  • Current clinical trial designs face challenges in yielding meaningful results.

Conclusions:

  • Pediatric heart failure is a unique entity requiring specialized approaches.
  • Targeted therapies and effective treatments necessitate further research into underlying mechanisms.
  • Novel clinical trial designs with relevant endpoints are crucial for advancing care.